$SEM
SELECT MEDICAL HOLDINGS CORP

2020 Q1 Form 10-Q Financial Statement

#000162828020005992 Filed on April 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $1.415B $1.325B
YoY Change 6.79% 5.72%
Cost Of Revenue $1.200B $1.132B
YoY Change 6.03% 6.22%
Gross Profit $214.3M $192.5M
YoY Change 11.32% 2.86%
Gross Profit Margin 15.15% 14.53%
Selling, General & Admin $33.80M $28.70M
YoY Change 17.77% -9.75%
% of Gross Profit 15.77% 14.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $51.80M $52.10M
YoY Change -0.58% 11.32%
% of Gross Profit 24.17% 27.06%
Operating Expenses $85.60M $80.80M
YoY Change 5.94% 2.93%
Operating Profit $128.7M $111.7M
YoY Change 15.17% 2.88%
Interest Expense $46.11M $50.81M
YoY Change -9.26% 7.73%
% of Operating Profit 35.83% 45.48%
Other Income/Expense, Net
YoY Change
Pretax Income $92.36M $71.81M
YoY Change 28.62% 27.61%
Income Tax $21.91M $18.47M
% Of Pretax Income 23.72% 25.72%
Net Earnings $53.13M $40.83M
YoY Change 30.1% 21.03%
Net Earnings / Revenue 3.76% 3.08%
Basic Earnings Per Share $0.40 $0.30
Diluted Earnings Per Share $0.40 $0.30
COMMON SHARES
Basic Shares Outstanding 129.6M shares 130.8M shares
Diluted Shares Outstanding 129.6M shares 130.9M shares

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $73.20M $147.8M
YoY Change -50.47% 23.48%
Cash & Equivalents $73.16M $147.8M
Short-Term Investments
Other Short-Term Assets $95.83M $117.5M
YoY Change -18.44% 25.0%
Inventory
Prepaid Expenses
Receivables $816.4M $779.9M
Other Receivables $0.00 $0.00
Total Short-Term Assets $998.0M $1.053B
YoY Change -5.21% 1.11%
LONG-TERM ASSETS
Property, Plant & Equipment $978.5M $972.8M
YoY Change 0.59% -0.07%
Goodwill $3.391B $3.324B
YoY Change 2.03% 0.15%
Intangibles $405.4M $426.4M
YoY Change -4.94% 0.42%
Long-Term Investments
YoY Change
Other Assets $327.6M $263.0M
YoY Change 24.55% 24.91%
Total Long-Term Assets $6.118B $5.969B
YoY Change 2.5% 21.13%
TOTAL ASSETS
Total Short-Term Assets $998.0M $1.053B
Total Long-Term Assets $6.118B $5.969B
Total Assets $7.116B $7.021B
YoY Change 1.34% 17.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $131.6M $140.6M
YoY Change -6.39% 1.55%
Accrued Expenses $687.1M $692.2M
YoY Change -0.74% 60.01%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $31.10M
YoY Change -100.0% 44.65%
Long-Term Debt Due $17.20M $12.30M
YoY Change 39.84% -45.33%
Total Short-Term Liabilities $844.0M $884.9M
YoY Change -4.63% 41.42%
LONG-TERM LIABILITIES
Long-Term Debt $3.553B $3.299B
YoY Change 7.7% -5.14%
Other Long-Term Liabilities $103.8M $105.8M
YoY Change -1.9% -36.7%
Total Long-Term Liabilities $103.8M $105.8M
YoY Change -1.9% -36.7%
TOTAL LIABILITIES
Total Short-Term Liabilities $844.0M $884.9M
Total Long-Term Liabilities $103.8M $105.8M
Total Liabilities $5.520B $5.264B
YoY Change 4.88% 19.74%
SHAREHOLDERS EQUITY
Retained Earnings $316.7M $313.6M
YoY Change 0.98% -18.25%
Common Stock $492.0M $488.4M
YoY Change 0.72% 4.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $808.6M $802.0M
YoY Change
Total Liabilities & Shareholders Equity $7.116B $7.021B
YoY Change 1.34% 17.64%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $53.13M $40.83M
YoY Change 30.1% 21.03%
Depreciation, Depletion And Amortization $51.80M $52.10M
YoY Change -0.58% 11.32%
Cash From Operating Activities $44.08M $41.76M
YoY Change 5.56% -17.67%
INVESTING ACTIVITIES
Capital Expenditures -$39.20M -$49.10M
YoY Change -20.16% 23.99%
Acquisitions $6.833M $6.120M
YoY Change 11.65% -98.81%
Other Investing Activities -$5.500M -$33.70M
YoY Change -83.68% -93.47%
Cash From Investing Activities -$44.66M -$82.80M
YoY Change -46.06% -85.11%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$262.1M $13.67M
YoY Change -2017.1% -97.28%
NET CHANGE
Cash From Operating Activities $44.08M $41.76M
Cash From Investing Activities -$44.66M -$82.80M
Cash From Financing Activities -$262.1M $13.67M
Net Change In Cash -$262.7M -$27.36M
YoY Change 860.12% 854.75%
FREE CASH FLOW
Cash From Operating Activities $44.08M $41.76M
Capital Expenditures -$39.20M -$49.10M
Free Cash Flow $83.28M $90.86M
YoY Change -8.34% 0.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001320414
CY2020Q1 sem Coronavirus Aid Relief And Economic Securities Cares Act Deferred Income Tax Liabilities
CoronavirusAidReliefAndEconomicSecuritiesCARESActDeferredIncomeTaxLiabilities
15500000 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
134328112 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
133823713 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
134328112 shares
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
133823713 shares
CY2019Q1 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
0
CY2019Q1 us-gaap Earnings Per Share Diluted Distributed
EarningsPerShareDilutedDistributed
0
CY2020Q1 us-gaap Earnings Per Share Diluted Distributed
EarningsPerShareDilutedDistributed
0
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2019Q4 us-gaap Assets
Assets
7340288000 USD
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2020Q1 dei Entity File Number
EntityFileNumber
001-34465
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
SELECT MEDICAL HOLDINGS CORP
CY2020Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1764048
CY2020Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
4714 Gettysburg Road
CY2020Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
P.O. Box 2034
CY2020Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Mechanicsburg
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2020Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
17055
CY2020Q1 dei City Area Code
CityAreaCode
717
CY2020Q1 dei Local Phone Number
LocalPhoneNumber
972-1100
CY2020Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2020Q1 dei Trading Symbol
TradingSymbol
SEM
CY2020Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
133977064 shares
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
335882000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
73163000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
762677000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
816405000 USD
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
18585000 USD
CY2020Q1 us-gaap Prepaid Taxes
PrepaidTaxes
12634000 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
95848000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
95828000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1212992000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
998030000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1003986000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1014969000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
998406000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
978547000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3391955000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
3391078000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
409068000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
405374000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
323881000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
327569000 USD
CY2020Q1 us-gaap Assets
Assets
7115567000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
207950000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
212884000 USD
CY2019Q4 sem Long Term Debt And Finance Lease Obligation Current
LongTermDebtAndFinanceLeaseObligationCurrent
25167000 USD
CY2020Q1 sem Long Term Debt And Finance Lease Obligation Current
LongTermDebtAndFinanceLeaseObligationCurrent
17161000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
145731000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
131601000 USD
CY2019Q4 sem Accrued Salaries Accrued Bonuses And Accrued Payroll Taxes Current
AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent
183754000 USD
CY2020Q1 sem Accrued Salaries Accrued Bonuses And Accrued Payroll Taxes Current
AccruedSalariesAccruedBonusesAndAccruedPayrollTaxesCurrent
140009000 USD
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
124111000 USD
CY2020Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
128705000 USD
CY2019Q4 us-gaap Interest Payable Current
InterestPayableCurrent
33853000 USD
CY2020Q1 us-gaap Interest Payable Current
InterestPayableCurrent
11339000 USD
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
191076000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
194165000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
2638000 USD
CY2020Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
8090000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
914280000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
843954000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
852897000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
860796000 USD
CY2019Q4 sem Long Term Debt And Finance Lease Obligation Noncurrent
LongTermDebtAndFinanceLeaseObligationNoncurrent
3419943000 USD
CY2020Q1 sem Long Term Debt And Finance Lease Obligation Noncurrent
LongTermDebtAndFinanceLeaseObligationNoncurrent
3553056000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
148258000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
158782000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
101334000 USD
CY2020Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
103783000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
5436712000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
5520371000 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
974541000 USD
CY2020Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
620377000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
134000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
134000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
491038000 USD
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
491824000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
279800000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
316680000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
770972000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
808638000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
158063000 USD
CY2020Q1 us-gaap Minority Interest
MinorityInterest
166181000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
929035000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
974819000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7340288000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7115567000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1324631000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1414632000 USD
CY2019Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1132092000 USD
CY2020Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1200371000 USD
CY2019Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28677000 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
33831000 USD
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52138000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
51752000 USD
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
1212907000 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
1285954000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
111724000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
128678000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4366000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2588000 USD
CY2019Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
6532000 USD
CY2020Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
7201000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
50811000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
46107000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
71811000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
92360000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18467000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21912000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
53344000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
70448000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12510000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17323000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
40834000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
53125000 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
929035000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
53125000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
10067000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6136000 USD
CY2020Q1 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
8691000 USD
CY2020Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
1679000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
6774000 USD
CY2020Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6833000 USD
CY2020Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-10123000 USD
CY2020Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-365000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
974819000 USD
CY2019Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
49073000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
916240000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
40834000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Nonredeemable Noncontrolling Interest
NetIncomeLossAttributableToNonredeemableNoncontrollingInterest
4810000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 USD
CY2019Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0 USD
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5488000 USD
CY2019Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
6837000 USD
CY2019Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
2480000 USD
CY2019Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-47470000 USD
CY2019Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-291000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
924550000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
53344000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
70448000 USD
CY2019Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
7872000 USD
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
8479000 USD
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
52138000 USD
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
51752000 USD
CY2019Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1567000 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
199000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4366000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2588000 USD
CY2019Q1 sem Gain Losson Dispositionof Assetsand Businesses
GainLossonDispositionofAssetsandBusinesses
6233000 USD
CY2020Q1 sem Gain Losson Dispositionof Assetsand Businesses
GainLossonDispositionofAssetsandBusinesses
7339000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6255000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6903000 USD
CY2019Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3231000 USD
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
553000 USD
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-81000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
9364000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
74752000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
53928000 USD
CY2019Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
7523000 USD
CY2020Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-27000 USD
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-57319000 USD
CY2020Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2248000 USD
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4324000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8992000 USD
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-69163000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-44455000 USD
CY2019Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
17830000 USD
CY2020Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
11413000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
39208000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
41762000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
44084000 USD
CY2019Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6120000 USD
CY2019Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
27608000 USD
CY2020Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
9848000 USD
CY2019Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
2000 USD
CY2020Q1 us-gaap Proceeds From Sales Of Business Affiliate And Productive Assets
ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets
11230000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-82799000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-44659000 USD
CY2019Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
360000000 USD
CY2020Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
460000000 USD
CY2019Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
220000000 USD
CY2020Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
295000000 USD
CY2019Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
132685000 USD
CY2020Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
39843000 USD
CY2019Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
8290000 USD
CY2020Q1 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
6487000 USD
CY2019Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
6155000 USD
CY2020Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
8099000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0 USD
CY2020Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
8691000 USD
CY2019Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
6050000 USD
CY2020Q1 us-gaap Increase Decrease In Book Overdrafts
IncreaseDecreaseInBookOverdrafts
0 USD
CY2019Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
3425000 USD
CY2020Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
1679000 USD
CY2019Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5251000 USD
CY2020Q1 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
12474000 USD
CY2019Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
0 USD
CY2020Q1 us-gaap Payments For Repurchase Of Redeemable Noncontrolling Interest
PaymentsForRepurchaseOfRedeemableNoncontrollingInterest
366203000 USD
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13674000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-262144000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27363000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-262719000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175178000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
335882000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147815000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
73163000 USD
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
37199000 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
67885000 USD
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
718000 USD
CY2020Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1135000 USD
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24176000 USD
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
67894000 USD
CY2020Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingencies, at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2017 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
1100000 USD
CY2018 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
-100000 USD
CY2019 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
3000000.0 USD
CY2020Q1 us-gaap Contract With Customer Asset Accumulated Allowance For Credit Loss
ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
0 USD
CY2020Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Credit Risk Concentrations</span></div><div style="line-height:120%;padding-bottom:12px;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash balances and accounts receivables. The Company’s excess cash is held with large financial institutions. The Company grants unsecured credit to its patients, most of whom reside in the service area of the Company’s facilities and are insured under third-party payor agreements. The Company’s general policy is to verify insurance coverage prior to the date of admission for patients admitted to its critical illness recovery hospitals and rehabilitation hospitals. Within the Company’s outpatient rehabilitation clinics, insurance coverage is verified prior to the patient’s visit. Within the Company’s Concentra centers, insurance coverage is verified or an authorization is received from the patient’s employer prior to the patient’s visit.</span></div>Because of the diversity in the Company’s non-governmental third-party payor base, as well as their geographic dispersion, patient accounts receivable which are due from the Medicare program represent the Company’s only significant concentration of credit risk.
CY2018Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
780488000 USD
CY2019Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
974541000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
7700000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Redeemable Noncontrolling Interest
NetIncomeLossAttributableToRedeemableNoncontrollingInterest
7256000 USD
CY2019Q1 sem Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests
NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
2771000 USD
CY2020Q1 sem Noncontrolling Interest Distributionsto Redeemable Noncontrolling Interests
NoncontrollingInterestDistributionstoRedeemableNoncontrollingInterests
5687000 USD
CY2019Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
0 USD
CY2020Q1 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
366203000 USD
CY2019Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-47470000 USD
CY2020Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-10123000 USD
CY2019Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
354000 USD
CY2020Q1 us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
347000 USD
CY2019Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
833241000 USD
CY2020Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
620377000 USD
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2588000 USD
CY2020Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
7201000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3391955000 USD
CY2020Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
5177000 USD
CY2020Q1 us-gaap Goodwill Written Off Related To Sale Of Business Unit
GoodwillWrittenOffRelatedToSaleOfBusinessUnit
6034000 USD
CY2020Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-20000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
3391078000 USD
CY2019Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
510216000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
101148000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
409068000 USD
CY2020Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
513728000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
108354000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
405374000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7100000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6900000 USD
CY2020Q1 sem Long Term Debt Gross And Finance Lease Obligation
LongTermDebtGrossAndFinanceLeaseObligation
3572054000 USD
CY2020Q1 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-28532000 USD
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
30369000 USD
CY2020Q1 sem Long Term Debt And Finance Lease Obligation
LongTermDebtAndFinanceLeaseObligation
3570217000 USD
CY2020Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
3453046000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
46107000 USD
CY2020Q1 sem Long Term Debt And Finance Lease Obligation Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtAndFinanceLeaseObligationRepaymentsOfPrincipalRemainderOfFiscalYear
14318000 USD
CY2020Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Two
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearTwo
8130000 USD
CY2020Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Three
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearThree
17215000 USD
CY2020Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Four
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFour
8121000 USD
CY2020Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal In Year Five
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalInYearFive
199700000 USD
CY2020Q1 sem Long Term Debt And Finance Lease Obligation Maturities Repayments Of Principal After Year Five
LongTermDebtAndFinanceLeaseObligationMaturitiesRepaymentsOfPrincipalAfterYearFive
3324570000 USD
CY2020Q1 sem Long Term Debt Gross And Finance Lease Obligation
LongTermDebtGrossAndFinanceLeaseObligation
3572054000 USD
CY2019Q4 sem Long Term Debt Gross And Finance Lease Obligation
LongTermDebtGrossAndFinanceLeaseObligation
3447221000 USD
CY2019Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-29577000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
31688000 USD
CY2019Q4 sem Long Term Debt And Finance Lease Obligation
LongTermDebtAndFinanceLeaseObligation
3445110000 USD
CY2019Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
3546524000 USD
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1324631000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1414632000 USD
CY2019Q1 sem Adjusted Ebitda
AdjustedEbitda
170117000 USD
CY2020Q1 sem Adjusted Ebitda
AdjustedEbitda
187333000 USD
CY2019Q1 us-gaap Assets
Assets
7021492000 USD
CY2020Q1 us-gaap Assets
Assets
7115567000 USD
CY2019Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
49073000 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
39208000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
111724000 USD
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4366000 USD
CY2019Q1 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
6532000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
50811000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
71811000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
128678000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
92360000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
51307000 USD
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
129638000 shares
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1324631000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1414632000 USD
CY2020Q1 us-gaap Earnings Per Share Basic Distributed
EarningsPerShareBasicDistributed
0
CY2019Q1 us-gaap Profit Loss
ProfitLoss
53344000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
70448000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
53344000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
70448000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12510000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17323000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
12510000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17323000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
40834000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
53125000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
40834000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
53125000 USD
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1343000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1818000 USD
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
1343000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
1818000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39491000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51307000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
39491000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
51307000 USD
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
39491000 USD
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
130821000 shares
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2019Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
39491000 USD
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
130861000 shares
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1343000 USD
CY2019Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
4449000 shares
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.30
CY2019Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
1343000 USD
CY2019Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
4449000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
40834000 USD
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
1818000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
40834000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51307000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129638000 shares
CY2020Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
4594000 shares
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
1818000 USD
CY2020Q1 us-gaap Incremental Common Shares Attributable To Participating Nonvested Shares With Non Forfeitable Dividend Rights
IncrementalCommonSharesAttributableToParticipatingNonvestedSharesWithNonForfeitableDividendRights
4594000 shares
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.40
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
53125000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
53125000 USD
CY2020Q1 sem Coronavirus Aid Relief And Economic Securities Cares Act Taxes Payable Current
CoronavirusAidReliefAndEconomicSecuritiesCARESActTaxesPayableCurrent
-15500000 USD

Files In Submission

Name View Source Status
0001628280-20-005992-index-headers.html Edgar Link pending
0001628280-20-005992-index.html Edgar Link pending
0001628280-20-005992.txt Edgar Link pending
0001628280-20-005992-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sem-20200331.xsd Edgar Link pending
sem-20200331_cal.xml Edgar Link unprocessable
sem-20200331_def.xml Edgar Link unprocessable
sem-20200331_lab.xml Edgar Link unprocessable
sem-20200331_pre.xml Edgar Link unprocessable
sem-331202010qxex311.htm Edgar Link pending
sem-331202010qxex312.htm Edgar Link pending
sem-331202010qxex321.htm Edgar Link pending
sem-331202010xq.htm Edgar Link pending
sem-331202010xq_htm.xml Edgar Link completed
Show.js Edgar Link pending